Examples of Antibiotic Stewardship Interventions
Some antibiotic stewardship interventions are deployed before antibiotics are prescribed, while others occur after a patient has already started taking antibiotics. Many initial interventions focus on educating clinicians, patients and members of the public on the risks associated with inappropriate antibiotic use.7 Hospitals also use antibiograms to aid clinicians in choosing appropriate antibiotics for their patients. Antibiograms provide information about susceptibility to a range of antibiotics, allowing physicians and other health care providers to prescribe the antibiotic that's most likely to treat an infection successfully.
Some hospitals are also fighting the problem of antibiotic resistance by creating lists of restricted antimicrobials and working to ensure that patient charts contain accurate information regarding antibiotic allergies. When an antibiotic is added to a list of restricted antimicrobials, that doesn't mean it can never be prescribed. Instead, use of the drug requires prior authorization, ensuring that only patients who really need the antibiotic receive it. In high-income countries, many patient charts are labeled with allergy warnings that turn out to be inaccurate. A study published in BMJ Global Health indicates that 90% to 95% of penicillin allergy labels are spurious, making the problem of antibiotic resistance even worse.8
Once antibiotics have been prescribed, dose optimization, duration optimization and timeouts are among the most common interventions. Dose optimization involves determining exactly the right dose of an antibiotic to administer to each patient. If the dose is too small, the risk of antibiotic resistance increases, but larger doses may lead to uncomfortable side effects. Duration optimization involves determining the right length of treatment. If a patient stops taking an antibiotic after a few days, remaining bacteria may become resistant to antimicrobials. Taking antibiotics for too long, however, increases the risk of adverse events.9
Some hospitals are using a highly effective intervention known as procalcitonin testing. Procalcitonin is a biomarker that can be used to determine if a patient is likely to have a bacterial infection and, if so, the seriousness of the infection.10 If a high-risk patient has signs of infection, PCT testing makes it easier for clinicians to determine if antibiotic therapy is required. For patients already receiving antibiotics, the test is a safe way to determine the right time to discontinue antibiotics. As a result, PCT testing is a valuable tool for optimizing the duration of antimicrobial use in a hospital setting.
PCT testing has been used to promote antibiotic stewardship in the treatment of sepsis, community-acquired pneumonia and SARS-CoV-2 patients.11 In the PROGRESS study, the use of PCT testing reduced the median antibiotic treatment duration by 50% (reducing it from 10 days to 5 days), reduced the 28-day mortality rate by 46% and drove down the costs of hospitalization by 19%, demonstrating the benefits of incorporating this type of testing into an antibiotic stewardship program.12